Novel indole alpha-methylene-gamma-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases

Bioorg Med Chem Lett. 2005 Nov 1;15(21):4799-802. doi: 10.1016/j.bmcl.2005.07.050.

Abstract

In an effort to generate novel anticancer agents, a series of hybrids of alpha-methylene-gamma-lactones and 2-phenyl indoles has been synthesized and evaluated for inhibition activities on the phosphorylation of AKT, mTOR, p70S6 kinase, and 4E-BP1. The results indicate that substitutes on the gamma-position of lactones have a rather significant influence on inhibition activities.

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology
  • Carrier Proteins / drug effects
  • Carrier Proteins / metabolism
  • Cell Cycle Proteins
  • Humans
  • Indoles / chemical synthesis*
  • Indoles / pharmacology
  • Lactones / chemical synthesis*
  • Lactones / pharmacology
  • Phosphoproteins / drug effects
  • Phosphoproteins / metabolism
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / chemical synthesis*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinases / drug effects*
  • Protein Kinases / metabolism
  • Ribosomal Protein S6 Kinases, 70-kDa / drug effects
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism
  • Signal Transduction / drug effects
  • Structure-Activity Relationship
  • TOR Serine-Threonine Kinases

Substances

  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents
  • Carrier Proteins
  • Cell Cycle Proteins
  • EIF4EBP1 protein, human
  • Indoles
  • Lactones
  • Phosphoproteins
  • Protein Kinase Inhibitors
  • Protein Kinases
  • MTOR protein, human
  • Ribosomal Protein S6 Kinases, 70-kDa
  • TOR Serine-Threonine Kinases